Bharti Sudhanshu Kumar, Krishnan Supriya, Kumar Ashwini, Kumar Awanish
Department of Biochemistry, Patna University, Patna, Bihar, India.
Department of PMIR, Patna University, Patna, Bihar, India.
Ther Adv Endocrinol Metab. 2018 Mar;9(3):81-100. doi: 10.1177/2042018818755019. Epub 2018 Feb 12.
Diabetes Mellitus, characterized by persistent hyperglycaemia, is a heterogeneous group of disorders of multiple aetiologies. It affects the human body at multiple organ levels thus making it difficult to follow a particular line of the treatment protocol and requires a multimodal approach. The increasing medical burden on patients with diabetes-related complications results in an enormous economic burden, which could severely impair global economic growth in the near future. This shows that today's healthcare system has conventionally been poorly equipped towards confronting the mounting impact of diabetes on a global scale and demands an urgent need for newer and better options. The overall challenge of this field of diabetes treatment is to identify the individualized factors that can lead to improved glycaemic control. Plants are traditionally used worldwide as remedies for diabetes healing. They synthesize a diverse array of biologically active compounds having antidiabetic properties. This review is an endeavour to document the present armamentarium of antidiabetic herbal drug discovery and developments, highlighting mechanism-based antidiabetic properties of over 300 different phytoconstituents of various chemical categories from about 100 different plants modulating different metabolic pathways such as glycolysis, Krebs cycle, gluconeogenesis, glycogen synthesis and degradation, cholesterol synthesis, carbohydrate metabolism as well as peroxisome proliferator activated receptor activation, dipeptidyl peptidase inhibition and free radical scavenging action. The aim is to provide a rich reservoir of pharmacologically established antidiabetic phytoconstituents with specific references to the novel, cost-effective interventions, which might be of relevance to other low-income and middle-income countries of the world.
糖尿病以持续性高血糖为特征,是一组病因多样的异质性疾病。它在多个器官层面影响人体,因此难以遵循特定的治疗方案,需要采取多模式方法。糖尿病相关并发症给患者带来的医疗负担不断增加,导致巨大的经济负担,这可能在不久的将来严重损害全球经济增长。这表明,当今的医疗体系传统上在应对糖尿病在全球范围内日益增加的影响方面准备不足,迫切需要更新更好的选择。糖尿病治疗领域的总体挑战是确定能够改善血糖控制的个体化因素。在世界各地,植物传统上被用作治疗糖尿病的药物。它们合成了各种各样具有抗糖尿病特性的生物活性化合物。本综述旨在记录目前抗糖尿病草药发现与开发的药物库,重点介绍来自约100种不同植物的300多种不同化学类别的植物成分基于机制的抗糖尿病特性,这些成分调节不同的代谢途径,如糖酵解、三羧酸循环、糖异生、糖原合成与降解、胆固醇合成、碳水化合物代谢以及过氧化物酶体增殖物激活受体激活、二肽基肽酶抑制和自由基清除作用。目的是提供一个丰富的已确立药理学抗糖尿病植物成分库,并特别提及可能与世界其他低收入和中等收入国家相关的新颖、具有成本效益的干预措施。